Skip to content

XOMA Corporation XOMA Net Investment in Lease

Net Investment in Lease at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Theravance Biopharma logo
Theravance BiopharmaTBPH
Innoviva, Inc. logo
Innoviva, Inc.INVA
Zymeworks logo
ZymeworksZYME
ALN
Alnylam PharmaceuticalsALNY
Xencor logo
XencorXNCR

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's net investment in lease?
XOMA Corporation (XOMA) reported net investment in lease of $239K in Q1 2026.
How has XOMA Corporation's net investment in lease changed year-over-year?
XOMA Corporation's net investment in lease decreased by 21.4% year-over-year, from $304K to $239K.
What is the long-term trend for XOMA Corporation's net investment in lease?
Over 5 years (2020 to 2025), XOMA Corporation's net investment in lease has grown at a -6.5% compound annual growth rate (CAGR), from $359K to $256K.